Literature DB >> 29062341

Changes in mediators of inflammation and pro-thrombosis after 12 months of dietary modification in adults with metabolic syndrome.

S K Rahamon1, U A Fabian1, M A Charles-Davies1, J A Olaniyi2, A A Fasanmade3, K S Akinlade1, O E Oyewole4, M O Owolabi2, J R Adebusuyi5, O O Hassan5, B M Ajobo6, M O Ebesunun7, K Adigun8, O O Popoola1, W Omiyale1, O G Arinola1, E O Agbedana1.   

Abstract

OBJECTIVE: This study evaluated the effects of a 12-month dietary modification on indices of inflammation and pro-thrombosis in adults with metabolic syndrome (MS).
MATERIALS AND METHODS: This longitudinal study involved 252 adults with MS recruited from the Bodija market, Ibadan and its environs. Participants were placed on 20%, 30% and 50% calories obtained from protein, total fat and carbohydrate respectively and were followed up monthly for 12 months. Anthropometry and blood pressure were measured using standard methods. Fasting plasma glucose (FPG), total cholesterol (TC), triglycerides (TG), high density lipoprotein-cholesterol (HDL-C), fibrinogen, plasminogen activator inhibitor-1 (PAI-1)], interleukin-6 (IL-6) and interleukin-10 (IL-10) were measured using spectrophotometric methods and ELISA as appropriate. Data was analysed using ANCOVA, Student's t-test, Mann-Whitney U and Wilcoxon signed-rank tests. P-values less than 0.05 were considered significant.
RESULTS: After 6 months of dietary modification, there was a significant reduction in waist circumference (WC), while the levels of HDL-C, fibrinogen and PAI-1 were significantly increased when compared with the corresponding baseline values. However, WC and fibrinogen reduced significantly, while HDL-C and IL-10 significantly increased after 12 months of dietary modification as compared with the respective baseline values.
CONCLUSION: Long-term regular dietary modification may be beneficial in ameliorating inflammation and pro-thrombosis in metabolic syndrome.

Entities:  

Keywords:  Dietary modification; fibrinogen; interleukins; metabolic syndrome; plasminogen activator inhibitor

Mesh:

Substances:

Year:  2017        PMID: 29062341      PMCID: PMC5637031          DOI: 10.4314/ahs.v17i2.20

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  50 in total

Review 1.  PAI-1 and the metabolic syndrome: links, causes, and consequences.

Authors:  Marie-Christine Alessi; Irène Juhan-Vague
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-24       Impact factor: 8.311

2.  Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant.

Authors:  Leopold Fezeu; Beverley Balkau; André-Pascal Kengne; Eugène Sobngwi; Jean-Claude Mbanya
Journal:  Atherosclerosis       Date:  2006-10-02       Impact factor: 5.162

3.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

Authors:  Katherine Esposito; Alessandro Pontillo; Carmen Di Palo; Giovanni Giugliano; Mariangela Masella; Raffaele Marfella; Dario Giugliano
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.

Authors:  Andreas Festa; Ken Williams; Russell P Tracy; Lynne E Wagenknecht; Steven M Haffner
Journal:  Circulation       Date:  2006-04-03       Impact factor: 29.690

6.  Fibrinogen in obesity before and after weight reduction.

Authors:  H H Ditschuneit; M Flechtner-Mors; G Adler
Journal:  Obes Res       Date:  1995-01

7.  Body fat distribution and 5-year risk of death in older women.

Authors:  A R Folsom; S A Kaye; T A Sellers; C P Hong; J R Cerhan; J D Potter; R J Prineas
Journal:  JAMA       Date:  1993-01-27       Impact factor: 56.272

Review 8.  Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome.

Authors:  E Maury; S M Brichard
Journal:  Mol Cell Endocrinol       Date:  2009-08-12       Impact factor: 4.102

9.  The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford
Journal:  Atherosclerosis       Date:  2003-06       Impact factor: 5.162

10.  Adipocyte death, adipose tissue remodeling, and obesity complications.

Authors:  Katherine J Strissel; Zlatina Stancheva; Hideaki Miyoshi; James W Perfield; Jason DeFuria; Zoe Jick; Andrew S Greenberg; Martin S Obin
Journal:  Diabetes       Date:  2007-09-11       Impact factor: 9.461

View more
  1 in total

1.  Sex-Specific Energy Intakes and Physical Activity Levels According to the Presence of Metabolic Syndrome in Korean Elderly People: Korean National Health and Nutrition Examination Survey 2016-2018.

Authors:  Won-Sang Jung; Hun-Young Park; Sung-Woo Kim; Kiwon Lim
Journal:  Int J Environ Res Public Health       Date:  2020-07-28       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.